Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 518926, 11 pages
http://dx.doi.org/10.1155/2015/518926
Research Article

Huangzhi Oral Liquid Prevents Arrhythmias by Upregulating Caspase-3 and Apoptosis Network Proteins in Myocardial Ischemia-Reperfusion Injury in Rats

1Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of TCM, Zhongshan, Guangdong 528400, China
2The Key Laboratory of Molecular Biology, State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China
3ZhuJiang Hospital of Southern Medical University, Guangdong, Guangzhou 510515, China

Received 5 April 2014; Accepted 7 July 2014

Academic Editor: Myeong Soo Lee

Copyright © 2015 Xu Ran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Vila-Petroff, M. A. Salas, M. Said et al., “CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury,” Cardiovascular Research, vol. 73, no. 4, pp. 689–698, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Q. Xie, W. Cui, Y. M. Hao et al., “Effects of remote preconditioning induced by skeletal muscle ischemia on myocardial cells apoptosis and roles of opioid receptors in pigs,” Chinese Journal of Applied Physiology, vol. 22, no. 4, pp. 474–478, 2006. View at Google Scholar
  3. Y. C. Zhou, B. Liu, Y. J. Li et al., “Effects of buyang huanwu decoction on ventricular remodeling and differential protein profile in a rat model of myocardial infarction,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 385247, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Y. Zeng, Y. Li, Y. Wan, Y. Zhang, and S. Liang, “Preparation and clinical efficacy of Huangzhi Oral liquid,” Chinese Journal of Hospital Pharmacy, no. 05, pp. P669–P670, 2007. View at Google Scholar
  5. X. S. Li, C. Miao, K. Lin, L. Gan, G. Huang, and Y. Zheng, “Clinical Studies of hypertension and left ventricular hypertrophy on the blood rheology,” Jouranl of New Chinese Medicine, no. 07, pp. 23–24, 2004. View at Google Scholar
  6. Y. Q. Gao, D. Su, H. Lin, and Q. Mei, “Effect of Huangzhi Oral liquid. on platelet aggregation,” Chinese Journal of Pharmacy, no. 15, pp. p1129–p1130, 2008. View at Google Scholar
  7. Y. Jia, L. Yu, and Y. Chen, “Effect of dingxin recipe on arrhythmia and injury induced by ischemia and reperfusion in rabbits,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 19, no. 11, pp. 678–681, 1999. View at Google Scholar · View at Scopus
  8. N. Himori and A. Matsuura, “A simple technique for occlusion and reperfusion of coronary artery in conscious rats,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 256, no. 6, pp. H1719–H1725, 1989. View at Google Scholar · View at Scopus
  9. M. J. A. Walker, M. J. Curtis, D. J. Hearse et al., “The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion,” Cardiovascular Research, vol. 22, no. 7, pp. 447–455, 1988. View at Publisher · View at Google Scholar · View at Scopus
  10. H. B. Cai, X. G. Sun, Z. F. Liu et al., “Effects of dahuangzhechong pills on cytokines and mitogen activated protein kinase activation in rats with hepatic fibrosis,” Journal of Ethnopharmacology, vol. 132, no. 1, pp. 157–164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Chen, H. Zhao, Y. Yang, B. Liu, J. Ni, and W. Wang, “Lipid-lowering and antioxidant activities of Jiang-Zhi-Ning in traditional chinese medicine,” Journal of Ethnopharmacology, vol. 134, no. 3, pp. 919–930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. E. M. El-Sayed, O. M. Abo-Salem, H. A. Aly, and A. M. Mansour, “Potential antidiabetic and hypolipidemic effects of propolis extract in streptozotocin-induced diabetic rats,” Pakistan Journal of Pharmaceutical Sciences, vol. 22, no. 2, pp. 168–174, 2009. View at Google Scholar · View at Scopus
  13. P. Jyothi, N. Riyaz, G. Nandakumar, and M. Binitha, “A study of oxidative stress in paucibacillary and multibacillary leprosy,” Indian Journal of Dermatology, Venereology and Leprology, vol. 74, no. 1, p. 80, 2008. View at Google Scholar · View at Scopus
  14. A. Godekmerdan, S. Arusan, B. Bayar, and N. Sağlam, “Medicinal leeches and hirudotherapy,” Türkiye Parazitolojii Dergisi, vol. 35, no. 4, pp. 234–239, 2011. View at Google Scholar
  15. J. Hildebrandt and S. Lemke, “Small bite, large impact-saliva and salivary molecules in the medicinal leech, Hirudo medicinalis,” Naturwissenschaften, vol. 98, no. 12, pp. 995–1008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. I. P. Baskova and L. L. Zavalova, “Polyfunctionality of destabilase, a lysozyme from a medicinal leech,” Bioorganicheskaia khimiia, vol. 34, no. 3, pp. 337–343, 2008. View at Google Scholar · View at Scopus
  17. J. Lv, S. Fu, J. Guo, Y. Liu, H. Yuan, and X. Xiao, “Primary research on daily administration times of rhubarb used to treat experimental jaundice in rats,” Zhongguo Zhongyao Zazhi, vol. 36, no. 24, pp. 3506–3510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Hu, Y. Lu, X. Dai, and Y. Pan, “Screening of antioxidant phenolic compounds in Chinese Rhubarb combining fast counter-current chromatography fractionation and liquid chromatography/mass spectrometry analysis,” Journal of Separation Science, vol. 33, no. 11, pp. 1595–1603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Sohn, S. Jang, H. Joo et al., “Anti-allergic and anti-inflammatory effects of butanol extract from Arctium Lappa L,” Clinical and Molecular Allergy, vol. 9, no. 1, article 4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Iwakami, J.-B. Wu, Y. Ebizuka, and U. Sankawa, “Platelet activating factor (PAF) antagonists contained in medicinal plants: lignans and sesquiterpenes,” Chemical and Pharmaceutical Bulletin, vol. 40, no. 5, pp. 1196–1198, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. L. H. Xie, E. Ahn, T. Akao, A. A. Abdel-Hafez, N. Nakamura, and M. Hattori, “Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria,” Chemical & Pharmaceutical Bulletin, vol. 51, no. 4, pp. 378–384, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. B. G. Sun, Z. Chen, S. Zhang, Y. Liu, H. Huang, and L. Yin, “Study of antitumous effect of the complex prescription of Chinese crude drug in athymic mice with HCC,” Zhong Yao Cai, vol. 30, no. 11, pp. 1417–1421, 2007. View at Google Scholar · View at Scopus
  23. X. Han, W. Wang, R. Tan, and D. Dou, “Determination of plasma protein binding rate of arctiin and arctigenin with ultrafiltration,” Zhongguo Zhongyao Zazhi, vol. 38, no. 3, pp. 432–434, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Almeida, “Genetic determinants of neuronal vulnerability to apoptosis,” Cellular and Molecular Life Sciences, vol. 70, no. 1, pp. 71–88, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Okouchi, O. Ekshyyan, M. Maracine, and Y. A. Tak, “Neuronal apoptosis in neurodegeneration,” Antioxidants & Redox Signaling, vol. 9, no. 8, pp. 1059–1096, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Chen and D. V. Goeddel, “TNF-R1 signaling: a beautiful pathway,” Science, vol. 296, no. 5573, pp. 1634–1635, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Wajant, “The Fas signaling pathway: more than a paradigm,” Science, vol. 296, no. 5573, pp. 1635–1636, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. M. E. Peter and P. H. Krammer, “The CD95(APO-1/Fas) DISC and beyond,” Cell Death and Differentiation, vol. 10, no. 1, pp. 26–35, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Singh, S. Pervin, and G. Chaudhuri, “Caspase-8-mediated BID cleavage and release of mitochondrial cytochrome c during Nω-hydroxy-L-arginine-induced apoptosis in MDA-MB-468 cells: antagonistic effects of L-ornithine,” Journal of Biological Chemistry, vol. 277, no. 40, pp. 37630–37636, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. L. P. Billen, A. Shamas-Din, and D. W. Andrews, “Bid: a Bax-like BH3 protein,” Oncogene, vol. 27, supplement 1, pp. S93–S104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. P. Bolaños, M. A. Moro, I. Lizasoain, and A. Almeida, “Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: therapeutic implications,” Advanced Drug Delivery Reviews, vol. 61, no. 14, pp. 1299–1315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. W. G. Tait and D. R. Green, “Mitochondria and cell death: outer membrane permeabilization and beyond,” Nature Reviews Molecular Cell Biology, vol. 11, no. 9, pp. 621–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Yuan and B. A. Yankner, “Apoptosis in the nervous system,” Nature, vol. 407, no. 6805, pp. 802–809, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Chittenden, C. Flemington, A. B. Houghton et al., “A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions,” The EMBO Journal, vol. 14, no. 22, pp. 5589–5596, 1995. View at Google Scholar · View at Scopus
  35. J. Martinou and R. J. Youle, “Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics,” Developmental Cell, vol. 21, no. 1, pp. 92–101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Kuwana, M. R. Mackey, G. Perkins et al., “Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane,” Cell, vol. 111, no. 3, pp. 331–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. S. N. Willis, J. I. Fletcher, T. Kaufmann et al., “Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak,” Science, vol. 315, no. 5813, pp. 856–859, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Xie, T. Koyama, J. Suzuki et al., “Coronary reperfusion following ischemia: different expression of Bcl-2 and bax proteins, and cardiomyocyte apoptosis,” Japanese Heart Journal, vol. 42, no. 6, pp. 759–770, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. D. S. McClintock, M. T. Santore, V. Y. Lee et al., “Bc1-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death,” Molecular & Cellular Biology, vol. 22, no. 1, pp. 94–104, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. C. C. Harris, “1995 Deichmann lecture—p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment,” Toxicology Letters, vol. 82-83, pp. 1–7, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Guttenplan, C. Lee, and W. H. Frishman, “Inhibition of myocardial apoptosis as a therapeutic target in cardiovascular disease prevention: focus on caspase inhibition,” Heart Disease, vol. 3, no. 5, pp. 313–318, 2001. View at Google Scholar · View at Scopus